XML 17 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common stock and additional paid-in capital
Retained earnings
Accumulated other comprehensive income (loss)
Beginning balance (in shares) at Dec. 31, 2015   10,753,855    
Beginning balance at Dec. 31, 2015 $ 167,498 $ 59,970 $ 106,673 $ 855
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 13,689   13,689  
Net unrealized gain on securities available for sale, net of tax 1,585     1,585
Net unrealized loss on cash flow hedging derivative instruments 58     58
Net unrealized loss on securities transferred from available for sale to held to maturity, net of tax (12)     (12)
Comprehensive income 15,320   13,689 1,631
Cash dividends declared (7,333)   (7,333)  
Equity compensation expense 215 $ 215    
Payment to repurchase of common stock (in shares)   (7,053)    
Payment to repurchase common stock (129)   (129)  
Tax benefit from vesting of restricted stock 32 $ 32    
Issuance of restricted stock (in shares)   21,847    
Proceeds from sale of common stock (in shares)   19,680    
Proceeds from sale of common stock $ 391 $ 391    
Ending balance (in shares) at Sep. 30, 2016 10,788,329 10,788,329    
Ending balance at Sep. 30, 2016 $ 175,994 $ 60,608 112,900 2,486
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 4,562      
Net unrealized gain on securities available for sale, net of tax (1,292)      
Net unrealized loss on securities transferred from available for sale to held to maturity, net of tax $ 9      
Ending balance (in shares) at Sep. 30, 2016 10,788,329 10,788,329    
Ending balance at Sep. 30, 2016 $ 175,994 $ 60,608 112,900 2,486
Beginning balance (in shares) at Dec. 31, 2016 10,793,946 10,793,946    
Beginning balance at Dec. 31, 2016 $ 172,521 $ 60,831 111,693 (3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 14,502   14,502  
Net unrealized gain on securities available for sale, net of tax 110     110
Net unrealized loss on cash flow hedging derivative instruments (128)     (128)
Net unrealized loss on securities transferred from available for sale to held to maturity, net of tax (11)     (11)
Comprehensive income 14,473   14,502 (29)
Cash dividends declared (7,682)   (7,682)  
Equity compensation expense 247 $ 247    
Payment to repurchase of common stock (in shares)   (5,560)    
Payment to repurchase common stock (153)   (153)  
Issuance of restricted stock (in shares)   18,850    
Proceeds from sale of common stock (in shares)   17,488    
Proceeds from sale of common stock $ 476 $ 476    
Ending balance (in shares) at Sep. 30, 2017 10,824,724 10,824,724    
Ending balance at Sep. 30, 2017 $ 179,882 $ 61,554 118,360 (32)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 4,982      
Net unrealized gain on securities available for sale, net of tax (240)      
Net unrealized loss on securities transferred from available for sale to held to maturity, net of tax $ (3)      
Ending balance (in shares) at Sep. 30, 2017 10,824,724 10,824,724    
Ending balance at Sep. 30, 2017 $ 179,882 $ 61,554 $ 118,360 $ (32)